Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Classifica tra le azioni #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Prezzo delle azioni
$1.11
Capitalizzazione di mercato
$27.17M
Variazione (1 giorno)
0.19%
Variazione (1 anno)
58.22%
Paese
KR
Scambia Dong Sung Bio Pharm.Co.,Ltd. (002210)

Categoria

Utile per Dong Sung Bio Pharm.Co.,Ltd. (002210)
Utile nel Mar 2026 TTM: $-18.85M
Secondo gli ultimi rapporti finanziari di Dong Sung Bio Pharm.Co.,Ltd., gli utili attuali della società sono $-18.85M. Nel 2023, la società ha registrato un utile di $-668.88K, un aumento rispetto a agli utili del 2022, che erano di $-1.47M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Dong Sung Bio Pharm.Co.,Ltd. dal 2007 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-18.85M 261.93%
2024 $-5.21M 678.53%
2023 $-668.88K -54.39%
2022 $-1.47M -60.19%
2021 $-3.68M -62.99%
2020 $-9.95M 31.12%
2019 $-7.59M 26.29%
2018 $-6.01M 1,031.31%
2017 $-531.32K -74.81%
2016 $-2.11M -433.12%
2015 $633.14K -123.13%
2014 $-2.74M -7.49%
2013 $-2.96M -187.69%
2012 $3.37M 123.65%
2011 $1.51M -133.49%
2010 $-4.50M -873.29%
2009 $582.51K -85.64%
2008 $4.06M 9.40%
2007 $3.71M 0.00%
Utile per aziende simili o concorrenti